bioGenous BIOTECH, Inc.—Leading Organoid CRDMO Technology Platform

bioGenous BIOTECH, Inc.
—Leading Organoid CRDMO Technology Platform

"The Organoid Chat" Live Stream / First Broadcast of the Year | How to Lock Down Your Organoids? Tune in to bioGenous video channel at 7 PM on Thursday.
Product Center / Standardized reagents have served the research and drug development markets.
Technical Services / An end-to-end CDMO platform for organoid technology.

Great News! bioGenous Received Nearly 100 Million Yuan in Series A Funding to Build a Global Leading One-Stop Organoid Modeling Platform.

This round of financing was led by SDIC Fund and saw existing shareholder Marathon Venture Partners significantly increase its investment proportion.

Learn More　>
The bioGenous Organoid Technology Training Program is Open for Registration!

Learn More　>
Leading International Organoid Models for COVID-19 Infection

Learn More　>

Automated Organoid Devices

Tumor Organoid Kits

Normal Tissue Organoid Kits

Whole-process Reagents for Organoid

IPS-Derived Organoids

Growth Factors and Small Molecules

Human Intestinal Organoids (iHIO) - Inquire for Pricing

分享到微信